The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.

Some FDA staff said Elsa often gave wrong answers, what experts call “hallucinations”, and has to be double-checked.

Credit: Nuvation Bio. The approval was supported by data from 2 single-arm, open-label clinical trials evaluating taletrectinib in 270 patients with histologically confirmed, ROS1-positive locally ...

HealthDay News — Mailed self-collection (SC) kits may increase participation in cervical cancer screening, according to a study published online June 6 in JAMA Internal Medicine.

HealthDay News — Health care employment growth decreased during the pandemic but recovered by 2024, according to a research letter published online June 5 in the Journal of the American Medical ...

HealthDay News — A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5 in the European Journal of Preventive ...

The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...

Mavyret is a fixed dose combination of the direct-acting antiviral agents, glecaprevir, a HCV NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor.

Gilead’s HIV treatment trials involving an investigational integrase strand inhibitor (GS-1720) and an investigational capsid inhibitor (GS-4182) have been put on clinical hold by the Food and Drug ...

HealthDay News — Rates of colorectal cancer detection through colonoscopy screening are similar for adults aged 45 to 49 years and 50 to 54 years, according to a research letter published online June ...

The ACIP is a federal advisory committee composed of medical and public health experts who make recommendations on the use of vaccines for adults and children in the US.

Nadunolimab is a fully humanized Fc-enhanced IgG1 monoclonal antibody targeting interleukin 1 receptor accessory protein.